Startup Aims to Revolutionize Drug Discovery

The advancement of genomics and proteomics via high-performance computing is drawing new companies into the drug discovery business. One such company, Gencom Inc., has developed a drug discovery platform based on the Intel Itanium 2 hardware. At April's Intel Developer's Forum, Gencom received an Honorable Mention in the Itanium Solutions Alliance's Humanitarian Impact awards for its use of Itanium to advance functional genomics. Story in

Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1